Fundamental Analysis of CVS Health Corp - Growth / Value Index
CVS - Valuation Highlights
Valuation Analysis
Tsr Value Index - Excellent Score of 95.00
Undervalued - Price to Intrinsic Value of 0.086
Price to Earning Ratio is 9.81 and EV to EBITDA is 8.50 suggesting company is undervalued.
Book Value in last 3 years is trending up
Valuation Key Ratios
| Ratio | TTM | Latest FY | Yoy Change | MRQ |
|---|---|---|---|---|
| Price to Earning | 10.11 | 8.77 | -52.31 % | |
| Price to Book | 1.00 | 0.969 | -9.41 % | 0.986 |
| Price to Sales | 0.205 | 0.214 | -9.74 % | |
| Enterprise Value to EBITDA Multiple | 8.65 | 8.17 | -44.97 % |
CVS - Profitability Highlights
Profitability Analysis
Earning Yield of 10.19 %
Company Earning excess return
Reasonable Dividend Yield of 4.77 %
Annual Net Profit in last 3 years is trending up
Tsr Profitability Index - Very Poor Score of 18.12
In the last three years, the company has given poor Net Margin
In the last three years, the company has given poor Returns on Assets
EPS decline for last four quarters
Profitability Key Ratios
| Ratio | TTM | Latest FY | Yoy Change | MRQ |
|---|---|---|---|---|
| Return On Equity | 9.92 | 11.08 | 89.61 % | 1.50 |
| Return On Asset | 2.95 | 3.39 | 86.61 % | 0.446 |
| Net Profit Margin | 2.03 | 2.44 | 89.27 % | 1.26 |
| Operating Profit Margin | 3.48 | 4.25 | 77.00 % | 2.57 |
| EBITDA Margin | 3.94 | 4.40 | 79.44 % | 3.88 |
Highlights
| Market Cap | 72409.74 M |
| Enterprise Value | 123051 M |
| Price/Book TTM | 1.00 |
| Outstanding Share | 1255.37 M |
| Float/ Outstanding Share | 99.75% |
| Dividend Yield | 4.62 % |
Share Holding
Guru Numbers
| Price/Graham No | 0.660 |
| Peter Lynch Ratio | 10.86 |
| Piotroski F Score | 6.00 |
| Altman Z Score | 2.08 |
| Sloan Ratio | -0.0226 |
| Peter Lynch Fair Value | 101.46 |
CVS - Growth Highlights
Growth Analysis
Tsr Growth Index - Excellent Score of 81.13
YoY Net Margin Jump by 89.27%
Annual sales of the company is increased for three years in a row
Steady increase in Total Assets for last 3 Years
Operating Cash Flow decreasing for last 3 year
Growth Key Fields
| Field | TTM | YoY Growth | QoQ Growth |
|---|---|---|---|
| Revenue | 360935 M | 7.86 % | 5.73 % |
| Gross Profit | -74863.00 M | 56.83 % | 9.48 % |
| EBITDA | 14228.00 M | 93.54 % | 11.27 % |
| Net Profit | 7321.00 M | 104.15 % | 45.60 % |
| EPS | 5.71 | 109.69 % | NA |
CVS - Stability Highlights
Stability Analysis
Stability Key Ratios
| Ratio | Latest FY | Yoy Change | MRQ |
|---|---|---|---|
| Debt to Equity Ratio | 0.770 | 1.33 % | 0.893 |
| Cash Ratio | 0.103 | -54.10 % | |
| Quick Ratio | 0.629 | -5.81 % | 0.614 |
| Shareholders Equity | 30.62 | -1.58 % | |
| Debt to EBITDA | 3.85 | -43.63 % |
Historical Valuation Ratios of CVS Health Corp
Historical Valuation Ratios
Loading ...
Historical Profitability Ratios of CVS Health Corp
Historical Profitability Ratios
Loading ...
Historical Efficiency Ratios of CVS Health Corp
Historical Efficiency Ratios
Loading ...
Historical Solvency Ratios of CVS Health Corp
Historical Solvency Ratios
Loading ...
Note : All Data Generated at the End of Trading Hours (EOD Data)